Nuvation Bio Inc. Class A Common Stock vs Vishay Intertechnology Inc. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Vishay Intertechnology Inc. Common Stock trades at $35.28 (market cap $5.66B). The key difference: Vishay Intertechnology Inc. Common Stock is far larger — about 3.3× Nuvation Bio Inc. Class A Common Stock's market cap, and Vishay Intertechnology Inc. Common Stock pays a 1.08% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Vishay Intertechnology Inc. Common Stock for 0 Days on average.
| NUVB | VSH | |
|---|---|---|
Market Cap | $1.71B | $5.66B |
Volume | 5,448,712 | 3,478,477 |
Sector | Health | Technology |
52-Week High | $9.54 | $64.90 |
52-Week Low | $3.41 | $11.82 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.30B | $5.45B |
Dividend Yield | — | 1.08% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Vishay Intertechnology manufactures discrete semiconductors and passive electronic components. Its products include diodes, MOSFETs, resistors, capacitors, and sensors.
Read more on VSH →